Table 2

Clinical presentation and antiplatelet protocols

Symptoms/antiplatelet regimen informationResults (n:57)
Total (%)
Clinical presentation
 SAH3 (5%)
 Headache11 (19%)
 Blurred vision/diplopia/visual disturbances7 (12, 3%)
 Nerve paralysis/neuralgia2 (4%)
 Pontine stroke, tetraparesis, dizziness, dysarthria, diplopia2 (4%)
 Seizures1 (2%)
 Asymptomatic/incidental31 (54%)
Antiplatelet regimen
 Aspirin + clopidogrel*33 (58%)
 Aspirin + ticagrelor*14 (25%)
 Aspirin + ticlopidine*2 (4%)
 Aspirin + prasugrel*4 (7%)
 Integrillin ± iv aspirin2 (4%)
 Tirofiban ± iv aspirin2 (4%)
Platelet function testing
 Not performed28 (49%)
 Hyporesponse to clopidogrel4 (7%)
 Hyperresponse to clopidogrel2 (4%)
 Hyporesponse to aspirin1 (2%)
 Normoresponders to aspirin and clopidogrel22 (39%)
  • *A minimum of 3 days before the intervention.

  • iv, intravenous; SAH, sub-arachnoid hemorrhage.